What is Gonadorelin?

The short answer

Gonadorelin is a lab-made form of the hormone that tells the body to make sex hormones.

  • What it is

    Native GnRH; pulses stimulate LH and FSH release.

  • What people look into

    Testosterone

Get updates on Gonadorelin

What it is

Type
GnRH (peptide)
Also known as
factrel, lutrepulse, gnrh, gonadorelin acetate
How it works
Native GnRH; pulses stimulate LH and FSH release.

Regulatory status

FDA-approved, discontinued How we label status

FDA status (as of October 4, 2026): Approved for people as Factrel in 1982 and Lutrepulse in 1989. Both have since been discontinued. The federal drug label site DailyMed lists gonadorelin only in drugs for animals

See Gonadorelin in the Index →

Federal (FDA)
Approved for people as Factrel in 1982 and Lutrepulse in 1989. Both have since been discontinued. The federal drug label site DailyMed lists gonadorelin only in drugs for animals
503A compounding
No 503A category; 503B Category 1 as approved-drug component (as of March 21, 2025)
WADA 2026
S2.2.1 (males)

Timeline

Scroll sideways to see all columns.

Timeline table
DateWhat happenedSource
FDA final rule amends the animal drug regulations to reflect approval of an abbreviated application for a gonadorelin diacetate tetrahydrate solution for dairy cattle.Federal Register, event of July 19, 1996, on federalregister.gov
FDA final rule amends the animal drug regulations to reflect approval of a second abbreviated application for a gonadorelin diacetate tetrahydrate solution for dairy cattle.Federal Register, event of November 13, 2002, on federalregister.gov

US enforcement actions

1 US enforcement action, in 2026.

Actions by US federal and state agencies whose documents name Gonadorelin. Each row links to the government's own document.

Scroll sideways to see all columns.

US enforcement actions table
DateAgencyActionDocument
FDAWarning letterFDA document, warning letter, June 17, 2026, on fda.gov

References

Sources as of October 4, 2026

  1. Drugs@FDA: www.accessdata.fda.gov/scripts/cder/daf/index.cfm (1 of 2)
  2. Drugs@FDA: www.accessdata.fda.gov/scripts/cder/daf/index.cfm (2 of 2)
  3. FDA: www.fda.gov/media/94164/download
  4. FDA warning letter, June 17, 2026
  5. WADA: www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf